ANDA 203343, held by Ph Health. Clindamycin Phosphate.
As of Nov 15, 2026, ANDA 203343 (Clindamycin Phosphate), held by Ph Health, was first approved by FDA on May 29, 2015, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 29, 2015 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clindamycin PhosphateEQ 1% BASE · solution;topical | Clindamycin Phosphate | Discontinued |
| Mar 5, 2020 | Supplement 1Labeling · Standard review | Approved | None posted |
| Mar 5, 2020 | Supplement 2Labeling · Standard review | Approved | None posted |
| May 29, 2015 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
